July 25, 2017 9:12 AM ET


Company Overview of Eagle Biologics, Inc.

Company Overview

Arsia Therapeutics, Inc. develops protein-based antibody drugs by use of technology. The company was incorporated in 2013 and is based in Waltham, Massachusetts. As of November 16, 2016, Eagle Biologics, Inc. operates as a subsidiary of Eagle Pharmaceuticals, Inc.

1000 Winter Street

Suite 3350

Waltham, MA 02451

United States

Founded in 2013

Key Executives for Eagle Biologics, Inc.

Chief Executive Officer
Age: 56
Co-Founder, President, and Chairman
Age: 54
Compensation as of Fiscal Year 2017.

Eagle Biologics, Inc. Key Developments

Arsia Therapeutics, Inc. Presents at 2016 BIO International Convention, Jun-08-2016 04:45 PM

Arsia Therapeutics, Inc. Presents at 2016 BIO International Convention, Jun-08-2016 04:45 PM. Venue: Moscone Center, San Francisco, California, United States. Speakers: Charles Wescott.

Arsia Therapeutics, Inc. and Biogen Sign Research Collaboration for the Development of Subcutaneous Biologics

Arsia Therapeutics, Inc. announced a collaboration with Biogen. Arsia and Biogen will focus on providing meaningful treatment administration improvements for hemophilia patients by enabling subcutaneous versions of treatments that are currently administered via intravenous infusion. The companies will combine expertise to research formulations that could be administered at home through convenient subcutaneous injections. As part of the collaboration, Biogen will also utilize Arsia’s patented formulation technology, which has broad based utility for the production of high-concentration subcutaneous dose forms of protein and antibody drugs critical for next-generation biologics. Arsia will receive an upfront payment and could be eligible to receive development, regulatory, launch and sales milestones of up to $100 million if multiple products are successfully commercialized. Arsia may also receive royalties on certain products arising from the collaboration.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

November 11, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eagle Biologics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.